Log in
Enquire now

List of Eutropics Pharmaceuticals patents

List of Eutropics Pharmaceuticals patents
List of Effector Therapeutics patents
List of Evernote patents
List of Ooma patents
List of AI molecular diagnostics companies
List of funding rounds for Securetech Innovations, Inc.
Patents where
Current Assignee
Name
is
Eutropics PharmaceuticalsEutropics Pharmaceuticals
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 8987271 2,2′-biphenazine compounds and methods useful for treating disease

Patent 8987271 was granted and assigned to Eutropics Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.

Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8987271
March 24, 2015
‌
US Patent 9360473 Assay system to identify therapeutic agents

Patent 9360473 was granted and assigned to Eutropics Pharmaceuticals on June, 2016 by the United States Patent and Trademark Office.

Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9360473
June 7, 2016
‌
US Patent 8168755 Antibodies specific to heterodimers of Bcl-2 family and uses thereof

Patent 8168755 was granted and assigned to Eutropics Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.

Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8168755
May 1, 2012
‌
US Patent 9351971 Substituted 2,2′-biphenazines for treating diseases

Patent 9351971 was granted and assigned to Eutropics Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.

Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9351971
May 31, 2016
‌
US Patent 9051305 Compositions and methods useful for treating diseases

Patent 9051305 was granted and assigned to Eutropics Pharmaceuticals on June, 2015 by the United States Patent and Trademark Office.

Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9051305
June 9, 2015
‌
US Patent 10793915 Context dependent diagnostics test for guiding cancer treatment

Patent 10793915 was granted and assigned to Eutropics Pharmaceuticals on October, 2020 by the United States Patent and Trademark Office.

Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10793915
October 6, 2020
‌
US Patent 9345700 Compositions and methods useful for treating diseases

Patent 9345700 was granted and assigned to Eutropics Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.

Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9345700
May 24, 2016
‌
US Patent 10732182 Method for predicting cancer sensitivity

Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10732182
August 4, 2020
‌
US Patent 10413549 Methods and compositions useful for treating diseases involving Bcl-2 family proteins with isoquinoline and quinoline derivatives

Patent 10413549 was granted and assigned to Eutropics Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office.

Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10413549
September 17, 2019
‌
US Patent 10765673 Methods and compositions useful for treating diseases involving Bcl-2 family proteins with quinoline derivatives

Patent 10765673 was granted and assigned to Eutropics Pharmaceuticals on September, 2020 by the United States Patent and Trademark Office.

Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10765673
September 8, 2020
‌
US Patent 10640803 Methods for determining chemosensitivity and chemotoxicity

Patent 10640803 was granted and assigned to Eutropics Pharmaceuticals on May, 2020 by the United States Patent and Trademark Office.

Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10640803
May 5, 2020
‌
US Patent 11656230 Method for predicting cancer sensitivity

Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
Eutropics Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11656230
May 23, 2023
12 results
0 selected
12 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us